The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2014

Filed:

Jan. 13, 2009
Applicants:

Martin F. Hentemann, Carlisle, MA (US);

William Scott, Guilford, CT (US);

Jill Wood, Ft. Collins, CO (US);

Jeffrey Johnson, North Branford, CT (US);

Aniko Redman, Durham, NC (US);

Ann-marie Bullion, King of Prussia, PA (US);

Leatte Guernon, Moodus, CT (US);

Inventors:

Martin F. Hentemann, Carlisle, MA (US);

William Scott, Guilford, CT (US);

Jill Wood, Ft. Collins, CO (US);

Jeffrey Johnson, North Branford, CT (US);

Aniko Redman, Durham, NC (US);

Ann-Marie Bullion, King of Prussia, PA (US);

Leatte Guernon, Moodus, CT (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 45/06 (2006.01); A61K 31/541 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/541 (2013.01); A61K 2300/00 (2013.01); C07D 487/04 (2013.01); A61K 31/519 (2013.01);
Abstract

This invention relates to novel sulfone 2I3-dihydroimidazo[1 l2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis mediated disorders, as a sole agent or in combination with other active ingredients.


Find Patent Forward Citations

Loading…